| Log in

Strides Arcolab secures US FDA approval for manufacturing facility in Italy

20 September, 2013

Bangalore-based Strides Arcolab Ltd has received a nod from US Food and Drug Administration (US FDA) for its manufacturing facility at Milan, Italy, the company said in a stock market disclosure.

The facility which has also secured approval from European Union (EU) and TGA Australia is expecting its first approval for a niche semisolid product.

“This approval marks our foray into attractive but complex semi-solid markets in the US. Our first product, which is expected by Q1 2014, has undergone extensive clinical trials. It will be marketed by one of the top 10 generic companies in the US market,” Manish Gupta, CEO – Pharma, Strides Arcolab, said.

Currently, the company is developing a portfolio of liquid and semi-solid products for the US and EU markets. It has over 12 products at various stages of development and approvals.

This US FDA nod brings reprieve for the company which recently received a warning letter from the nodal drug administration body against the sterile manufacturing facility of Agila Specialities Pvt Ltd, its wholly owned subsidiary.

This could prove to be a dampener for the company as it in the last leg of the deal to sell Agila Specialties to US-based Mylan Inc for $1.6 billion. Mylan recently got the green signal from the Indian authorities to bring in money for the deal.

The current development comes amid the recent crackdown on Indian pharma companies by US FDA. Recently the US drug regulator issued an import alert against Ranbaxy’s Mohali facility, banning all drugs made in the unit from getting exported to the US, the largest drug market in the world.

(Edited by Joby Puthuparampil Johnson)


Leave Your Comment
Ahead of sale to Mylan, Agila Specialities receives warning from US FDA

Ahead of sale to Mylan, Agila Specialities receives warning from US FDA

TEAM VCC 4 years ago
Bangalore-based Agila Specialities Pvt Ltd, a wholly owned subsidiary of Strides...
Strides Arcolab receives US FDA approval for skin care drug

Strides Arcolab receives US FDA approval for skin care drug

Jasleen Kaur Batra 4 years ago
Strides Arcolab, a Bangalore-based pharmaceutical company with a focus on...
Strides Arcolab completes sale of Agila to Mylan for over $1.75B

Strides Arcolab completes sale of Agila to Mylan for over $1.75B

Anuradha Verma 4 years ago
Drug firm Strides Arcolab Ltd has completed sale of its specialties division...
No Comments

Strides Arcolab secures US FDA approval for manufacturing facility in Italy

Powered by WordPress.com VIP